Table A3.
All Survey Respondents | With Prelottery Diagnosis of Depression | Without Prelottery Diagnosis of Depression | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Control Mean | Effect of Medicaid Coverage | p‐Value | Control Mean | Effect of Medicaid Coverage | p‐Value | Control Mean | Effect of Medicaid Coverage | p‐Value | p‐Value for Difference Between (7) and (11) | |
(1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | |
Diagnosis of depression | ||||||||||
Postlottery diagnosis of depression (%) | N/A | N/A | 7.39 | 5.50 | 0.049 | |||||
(2.79) | ||||||||||
Undiagnosed depression (%) | N/A | N/A | 14.01 | −6.76 | 0.047 | |||||
(3.40) | ||||||||||
Treatment | ||||||||||
Talk therapy (%) | N/A | 37.4 | 8.83 | 0.196 | N/A | |||||
(6.84) | ||||||||||
Prescription medications | ||||||||||
Any mental health medication (%)b | 20.7 | 8.77 | 0.008 | 44.8 | 14.53 | 0.041 | 7.7 | 7.58 | 0.005 | 0.362 |
(3.33) | (7.10) | (2.67) | ||||||||
Mental health medications (#)b | 0.335 | 0.14 | 0.025 | 0.771 | 0.28 | 0.077 | 0.099 | 0.11 | 0.004 | 0.301 |
(0.77) | (0.06) | (1.07) | (0.16) | (0.38) | (0.04) | |||||
Share using any (%): | ||||||||||
Antidepressantc | 16.8 | 5.49 | 0.071 | 37.5 | 9.87 | 0.152 | 5.7 | 4.76 | 0.033 | 0.484 |
(3.04) | (6.88) | (2.23) | ||||||||
SSRI | 9.8 | 4.13 | 0.088 | 22.6 | 8.45 | 0.157 | 2.9 | 2.96 | 0.069 | 0.376 |
(2.42) | (5.96) | (1.62) | ||||||||
Tricyclic, MAOI, or Other | 7.0 | 3.66 | 0.082 | 15.8 | 6.32 | 0.227 | 2.3 | 2.87 | 0.051 | 0.529 |
(2.10) | (5.23) | (1.47) | ||||||||
Trazodone | 3.4 | −0.46 | 0.747 | 7.4 | −2.70 | 0.457 | 1.2 | 0.96 | 0.342 | 0.329 |
(1.42) | (3.62) | (1.01) | ||||||||
Anxiolytic | 6.2 | 2.60 | 0.207 | 14.1 | 7.11 | 0.171 | 2.0 | 0.81 | 0.553 | 0.242 |
(2.06) | (5.20) | (1.37) | ||||||||
Bipolar | 5.5 | 0.39 | 0.834 | 12.8 | 1.89 | 0.690 | 1.5 | −0.77 | 0.523 | 0.584 |
(1.85) | (4.73) | (1.21) | ||||||||
Sedative | 2.9 | 4.13 | 0.004 | 6.1 | 6.95 | 0.045 | 1.2 | 2.94 | 0.013 | 0.274 |
(1.43) | (3.47) | (1.18) | ||||||||
Antipsychotic | 4.0 | 0.80 | 0.629 | 9.8 | −0.61 | 0.887 | 0.8 | 1.81 | 0.075 | 0.582 |
(1.64) | (4.28) | (1.02) | ||||||||
Untreated depression (%)d | 16.6 | −10.50 | 0.001 | 20.1 | −17.00 | 0.003 | 14.8 | −6.80 | 0.053 | 0.128 |
(3.05) | (5.74) | (3.50) | ||||||||
Unmet need for mental health care (%) | 24.41 | −9.21 | 0.005 | 45.82 | −12.31 | 0.071 | 12.87 | −6.19 | 0.041 | 0.438 |
(3.29) | (6.82) | (3.03) |
For each sample, the first column reports the control mean of the dependent variable (with standard deviation for continuous outcomes in parentheses). The second column reports the estimated local average treatment effect of Medicaid coverage (with standard error in parentheses). See Appendix for estimating equation. All regressions include indicators for the number of household members on the lottery list and adjust standard errors for household clusters. The final column reports the p‐value for a test for treatment effect heterogeneity by prelottery diagnosis of depression. All analysis is weighted using survey weights. Samples consist of all in‐person interview respondents (n = 12,229), those with a pre‐lottery diagnosis of depression (n = 4,166) and those without (n = 8,063).
Trazodone and branded equivalents are excluded from these summary measures.
Aggregate result for all survey respondents previously reported in Baicker et al 2013.8
This analysis was not prespecified.